C-ZIMKAisa Therapeutics
anti-inflammatory, anti-senescence, nutraceuticals
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-ZIMK
C-ZIMKC-ZIMKanti-inflammatory, anti-senescence, nutraceuticals
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Aisa Therapeutics anti-inflammatory, anti-senescence, nutraceuticals
AISA Therapeutics was founded in October 2005 by Pr Dr Patrizia Anna d'Alessio, MD PhD. The company develops and commercializes non-toxic anti-inflammatory and anti-senescence products based on a concept that inflammation underlies aging. Its product areas include nutraceutical capsules and cosmeceutical brumes and serum under the AISA moleculum brand.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Aisa Therapeutics — Far from goals · Bottom quartile. Derived deterministically from 3 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…
Source: Deterministic